Peptide red flags
Pharmacy staff should be ready to advise caution whenever a customer describes self-injecting a substance bought online, particularly one labelled as a ‘research chemical’ rather than a medicine. These products are not subject to any quality control, so their actual contents, sterility and potency can vary between batches, as well as between what the label claims and what is really inside the vial. Self-administered injections also carry an infection risk if equipment or technique are not sterile.
In addition, staff should be especially alert to customers with pre-existing health conditions such as diabetes, a history of cancer or hormone-sensitive conditions, and to anyone who mentions new or changing moles, unexplained swelling, persistent injection-site problems or symptoms that could suggest a hormonal imbalance.
Younger customers, or anyone who seems to be feeling under pressure from what they have seen online, might benefit from a more in-depth conversation, as well as referral to the pharmacist, and where appropriate, their GP. As always, suspected adverse reactions to any product (licensed or unlicensed) can be reported through the MHRA’s Yellow Card scheme, which can be mentioned to customers directly.
“There is no human trial evidence”
The important part to stress to anyone adamant about trying a peptide is that the only route with genuine regulatory oversight is a prescription medicine, discussed with a qualified prescriber who has access to the person’s health history, rather than choosing a product bought through a social media link.
While some peptide-based medicines are among the most valuable tools in modern pharmacy, what is being sold on social media is often a different thing altogether: unlicensed, unverified products marketed with confident health claims they have not earned. The role of the pharmacy team is to meet customers where they are in their exploration of peptides, and make sure they have accurate information about the reality of these products, and how to access them appropriately.
Scenario
Pharmacy counter assistant Tash is serving Suzie, a regular customer in her late twenties.
Suzie: I wanted to ask you about something quietly. Have you heard of BPC-157? I’ve seen loads of people talking about it on TikTok, saying it heals injuries really fast, and it’s supposed to help with fat loss too. I’ve found a couple of suppliers and I was thinking of getting some online.
Tash: I have seen it mentioned, yes. It’s come up a lot recently. Can I ask what you’re hoping it would help you with?
Suzie: I’ve had a dodgy knee for a few months and I’m also just trying to shift some weight from my summer holiday, and it seems like it does both.
Tash: I get it. Those are two really common goals. I should say though, BPC-157 isn’t a licensed medicine here in the UK. It’s mostly been studied in animals rather than people, and it’s actually been flagged by medicines regulators over safety concerns, including the immune system reacting to it. The products sold online for injecting yourself aren’t quality-checked either, so you can’t really be sure what’s in the vial they send to you.
Suzie: Oh, I didn’t realise it wasn’t approved for people. I just saw it everywhere and assumed it must be fine.
Tash: It’s an easy assumption to make when it’s all over social media. For your knee, it might be worth having a proper look at what’s actually going on there first. Have you had a GP or physio referral yet? That could get you a diagnosis and a recovery plan that’s actually evidence-based. And for weight loss, if you’ve tried diet and exercise changes and they haven’t been enough, that’s something I could get the pharmacist to talk through with you in more detail, including whether a licensed weight-loss medicine might be appropriate.
Suzie: That’s actually really helpful, I hadn’t thought about that. Could I have a chat with the pharmacist about the weight loss side then please?
Tash: Of course, I’ll tell them you’d like a word. And do let us know how you get on with having your knee looked at properly too.